Fuzzy Panda Short Report Sends BillionToOne Down 10%
BLLN sits 42% above its 52-week low of $61.96 on light trading volume (0.3× avg).
Summary
Fuzzy Panda Research published a short report on BillionToOne and disclosed it is short the stock; shares fell 10% on the news. The company has not responded to a request for comment. This is the first short-seller attack in the recent record and lands just two weeks after Q3 results showed revenue of $123.0 million, up 47%, and $17.4 million of net income — a strong print that the short thesis will now be measured against. Short interest sits at 6.9%, so the report hits an already-contested name. BillionToOne presents at the Piper Sandler healthcare conference on Dec. 1, the next scheduled venue for management to answer the allegations.
At the time of this announcement, BLLN was trading at $87.83 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $61.96 to $150.44. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Seeking Alpha.